ATN-103

· Ablynx (a Sanofi company)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ATN-103, covering 2013-01-16 to 2016-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis [Phase 2]